上交所傅浩：科创板有很强的国际基因，正发展成为国际化市场

Core Viewpoint - The Shanghai Stock Exchange (SSE) emphasizes the internationalization of the Sci-Tech Innovation Board (STAR Market), highlighting its friendly investment ecosystem for international investors and its significant growth in the biopharmaceutical sector [1][2]. Group 1: Internationalization and Investment Ecosystem - The STAR Market is developing into an international market with strong international characteristics [1]. - The biopharmaceutical sector in China has seen rapid growth in business development (BD), accounting for 38% of global BD transactions this year [1]. - Foreign investment participation in the STAR Market is increasing, facilitated by mechanisms such as QFII and RQFII, as well as the Shanghai-Hong Kong Stock Connect [1]. Group 2: Investor Relations and Communication - STAR Market companies prioritize communication with international investors, conducting 3,425 performance briefings and international roadshows [2]. - The introduction of bilingual presentations and short videos aims to enhance global investors' understanding of China's innovation value [2]. Group 3: Future Developments and Market Reforms - The SSE plans to deepen capital market reforms to provide clearer visibility and stability for international investors [2]. - The STAR Market aims to empower technological progress and support high-quality financial development in line with China's modernization goals [2].